Impact of nontuberculous mycobacteria on the performance of Xpert MTB/RIF and Xpert MTB/RIF Ultra for the detection of tuberculosis and rifampin resistance: a diagnostic accuracy study
Original article Sangsoo Jung1,2, Eunsang Suh1*, Jun-Ki Lee1, Byung Woo Jhun3, Tae Yeul Kim1, Hee Jae Huh1,2, Nam Yong Lee1 1Department of Laboratory Medicine and Genetics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea2Department of Medical Device Management and Research, Samsung Advanced Institute for Health Sciences & Technology, Sungkyunkwan University, Seoul, Korea3Division of Pulmonary and Critical Care Medicine, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea*Current affiliation: Department of Laboratory Medicine, Gimpo Woori Hospital, Gimpo, Korea Correspondence to Hee Jae Huh, E-mail: pmhhj77@gmail.com; Tae Yeul Kim, E-mail: voltaire0925@gmail.com Ann Clin Microbiol 2025;28(4):21. https://doi.org/10.5145/ACM.2025.28.4.2Received on 13 August 2025, Revised on 14 September 2025, Accepted on 12 October 2025, Published on 01 December 2025.Copyright © Korean Society of Clinical Microbiology.This is an Open Access article which is freely available under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/). Abstract Background: The growing burden of